Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideMRKMerck & Co.
FinDog View：Neutral
VRTXVertex Pharmaceuticals
FinDog View：Neutral
| Metric | MRK | VRTX |
|---|
| Close | 144.91 | 513.26 |
| Market Cap | $358B | $121B |
| 1M | +6.57% | −0.44% |
| P/E (TTM) | 112.2 | 29.7 |
| Forward P/E | 19.5 | 24.0 |
| P/E 5-Yr Percentile | 81 | 52 |
| P/S | 5.4 | 10.4 |
| P/B | 8.5 | 6.5 |
| Dividend Yield | 2.87% | — |
| Latest Quarter Revenue | $16.6B | $3.3B |
| Revenue YoY | +5.1% | +12.5% |
| Gross Margin | 73.5% | 85.3% |
| Latest Quarter EPS | -0.54 | 4.31 |
| Avg Post-Earnings Move | ±1.7% | ±6.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.50% | 1.66% |
| 90-Day Net Insider Buying | −$30.0M | −$2.8M |
MRK · Revenue, Last 8 Quarters ($B)
VRTX · Revenue, Last 8 Quarters ($B)
